AimedBio IPO Raises Hopes Of Investor Appetite For Korean Biotech

Out-Licensing Deals Fuel Optimism

 
• By Jung Won Shin
  
IPO
Strong Performance Of Recent Kosdaq Debutants Helps AimedBio's IPO (Shutterstock)

More from Financing

More from Business